What one share of Kestra Medical Technologies holds
We are a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights.
Kestra Medical Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-31; the balance sheet is as of 2026-07-31.
| Sales | $1.91 |
|---|---|
| Profit | −$2.68 |
| Capex (buildings and equipment) | $0.63 |
| Free cash flow | −$2.19 |
| Cash and investments | $1.16 |
| Debt | $1.22 |
| Book value | $3.75 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $1.40 | −$5.07 | $0.61 | −$4.25 | — | — |
| 2025 | $2.43 | −$5.13 | $0.93 | −$4.09 | — | — |
| 2026 | $1.76 | −$2.43 | $0.64 | −$2.15 | — | $4.45 |
Common questions about Kestra Medical Technologies
How much does one share of Kestra Medical Technologies earn?
Over the last 12 months, Kestra Medical Technologies lost $2.68 for each share on $1.91 of sales.
Does Kestra Medical Technologies pay a dividend?
Kestra Medical Technologies didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Kestra Medical Technologies’s book value per share?
Kestra Medical Technologies’s book value is $3.75 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of July 31, 2026.
How much cash and debt does each share of Kestra Medical Technologies have?
Each share of Kestra Medical Technologies has $1.16 of cash and investments and $1.22 of debt, as of July 31, 2026.
What is Kestra Medical Technologies’s free cash flow per share?
−$2.19 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.